Skip to main navigation Skip to search Skip to main content

High altitude reduces infection rate of COVID-19 but not case-fatality rate

  • José Segovia Juarez
  • , Jesús Martin Castagnetto Mizuaray
  • , Gustavo F. Gonzales

Research output: Contribution to journalArticle (Contribution to Journal)peer-review

74 Scopus citations

Abstract

Coronavirus disease 19 (COVID-19) is a pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is suggested that life at high altitude may reduce COVID infections and case-fatality rates (cases/deaths). We study data from Peru COVID-19 pandemics, which first case was recorded on March 6th, 2020. By June 13, 2020 there were 6498 deaths, and 224,132 SARS-CoV-2 positives. Using data from 185 capitals of provinces with altitudes ranging from 3 to 4342¿m, we confirm previous reports that infection with COVID-19 at high altitude is reduced. However, case-fatality rate is not dependent of altitude. We have also presented first evidence that female protection towards death by COVID-19 is reduced as altitude of residence increases.
Original languageAmerican English
JournalRespiratory Physiology & Neurobiology
DOIs
StatePublished - 1 Jan 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'High altitude reduces infection rate of COVID-19 but not case-fatality rate'. Together they form a unique fingerprint.

Cite this